Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Midazolam × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Neoplasms 2 Melanoma 2 Advanced Malignancies 2 Urothelial Cancer 1 Thyroid Neoplasms 1 Solid Tumors, KRAS Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Hematologic Neoplasms 1 Healthy Adult Participants 1 Glioma 1 Colorectal Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡